Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 4/2018

01-04-2018 | Gynecologic Endocrinology and Reproductive Medicine

Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care

Authors: Samer Tannus, Justin Tan, Weon-Young Son, Michael-Haim Dahan

Published in: Archives of Gynecology and Obstetrics | Issue 4/2018

Login to get access

Abstract

Objective

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive age women. The clinical symptoms of PCOS vary with female age, as older women tend to have lower hyperandrogenic symptoms and many regain regular cycles. In this study, we aimed to estimate the prevalence of PCOS among older women referred for fertility care, describe their clinical characteristics, and compare their reproductive outcomes to those of matched control group.

Methods

A retrospective study conducted at a single reproductive center. All women aged ≥ 40, who were referred for in-vitro fertilization (IVF), between the years 2011–2015 were screened for possible inclusion. The PCOS diagnosis (was) made based on the Rotterdam criteria. The reproductive outcomes of the PCOS group were compared to those of matched control with tubal infertility.

Results

During the study period, 1427 women, aged 40 years and over, underwent a total of 2124 IVF cycles. Of these, 72 (5%) women were diagnosed with PCOS. In 69 (95.6%), the PCOS diagnosis was made by a combination of polycystic ovary morphology (PCOM) and anovulation. Compared to women with tubal factor infertility, women with PCOS needed lower doses of gonadotropins, had higher number of retrieved oocytes (16.6 vs. 10.4) and higher number of cycles with embryo cryopreservation (47 vs. 22.9%). This resulted in higher cumulative live birth in the PCOS group (26.3 vs. 15.2%, p = 0.04).

Conclusion

PCOS comprised 5% of the infertility diagnosis in women aged ≥ 40; PCOM and anovulation were the most prominent features. The higher oocyte number resulted in improved cumulative live birth rate.
Literature
1.
go back to reference March WA et al (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25(2):544–551CrossRefPubMed March WA et al (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 25(2):544–551CrossRefPubMed
2.
go back to reference ESHRE, The Thessaloniki, and ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89(3):505–522CrossRef ESHRE, The Thessaloniki, and ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89(3):505–522CrossRef
3.
go back to reference Balen A, Michelmore K (2002) What is polycystic ovary syndrome? Are national views important? Hum Reprod 17(9):2219–2227CrossRefPubMed Balen A, Michelmore K (2002) What is polycystic ovary syndrome? Are national views important? Hum Reprod 17(9):2219–2227CrossRefPubMed
4.
go back to reference Carmina E (2004) Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol 56(1):1–6PubMed Carmina E (2004) Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecol 56(1):1–6PubMed
5.
go back to reference Rotterdam, E. S. H. R. E., and ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41–47CrossRef Rotterdam, E. S. H. R. E., and ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1):41–47CrossRef
6.
go back to reference Azziz R et al (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91(2):456–488CrossRefPubMed Azziz R et al (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91(2):456–488CrossRefPubMed
7.
go back to reference Christ JP, Gunning MN, Fauser B (2017) Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis. Reprod Biomed Online 35(4):480–483CrossRefPubMed Christ JP, Gunning MN, Fauser B (2017) Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis. Reprod Biomed Online 35(4):480–483CrossRefPubMed
9.
go back to reference Gardner DK et al (2000) Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 73(6):1155–1158CrossRefPubMed Gardner DK et al (2000) Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 73(6):1155–1158CrossRefPubMed
10.
go back to reference Liang SJ et al (2011) Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod 26(12):3443–3449CrossRefPubMed Liang SJ et al (2011) Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod 26(12):3443–3449CrossRefPubMed
11.
go back to reference Elting MW et al (2000) Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 15(1):24–28CrossRefPubMed Elting MW et al (2000) Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 15(1):24–28CrossRefPubMed
12.
go back to reference Carmina E et al (2012) Does the level of serum antimullerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging? Fertil Steril 98(4):1043–1046CrossRefPubMed Carmina E et al (2012) Does the level of serum antimullerian hormone predict ovulatory function in women with polycystic ovary syndrome with aging? Fertil Steril 98(4):1043–1046CrossRefPubMed
13.
go back to reference Franks S, Stark J, Hardy K (2008) Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14(4):367–378CrossRefPubMed Franks S, Stark J, Hardy K (2008) Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14(4):367–378CrossRefPubMed
14.
go back to reference Hughesdon PE (1982) Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis”. Obstet Gynecol Surv 37(2):59–77CrossRefPubMed Hughesdon PE (1982) Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis”. Obstet Gynecol Surv 37(2):59–77CrossRefPubMed
15.
go back to reference Piltonen T et al (2005) Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20(7):1820–1826CrossRefPubMed Piltonen T et al (2005) Serum anti-mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 20(7):1820–1826CrossRefPubMed
16.
go back to reference Laven JS et al (2004) Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89(1):318–323CrossRefPubMed Laven JS et al (2004) Anti-mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 89(1):318–323CrossRefPubMed
17.
go back to reference Hudecova M et al (2009) Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 24(5):1176–1183CrossRefPubMed Hudecova M et al (2009) Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. Hum Reprod 24(5):1176–1183CrossRefPubMed
18.
go back to reference Alsamarai S et al (2009) Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab 94(12):4961–4970CrossRefPubMedPubMedCentral Alsamarai S et al (2009) Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab 94(12):4961–4970CrossRefPubMedPubMedCentral
19.
go back to reference Vulpoi C et al (2007) Ageing and reproduction: is polycystic ovary syndrome an exception? Ann Endocrinol (Paris) 68(1):45–50CrossRef Vulpoi C et al (2007) Ageing and reproduction: is polycystic ovary syndrome an exception? Ann Endocrinol (Paris) 68(1):45–50CrossRef
20.
go back to reference Meldrum DR et al (2013) Role of decreased androgens in the ovarian response to stimulation in older women. Fertil Steril 99(1):5–11CrossRefPubMed Meldrum DR et al (2013) Role of decreased androgens in the ovarian response to stimulation in older women. Fertil Steril 99(1):5–11CrossRefPubMed
21.
go back to reference Kalra SK, Ratcliffe SJ, Dokras A (2013) Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate. Fertil Steril 100(1):208–213CrossRefPubMed Kalra SK, Ratcliffe SJ, Dokras A (2013) Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate. Fertil Steril 100(1):208–213CrossRefPubMed
Metadata
Title
Prevalence, clinical characteristics, and reproductive outcomes of polycystic ovary syndrome in older women referred for tertiary fertility care
Authors
Samer Tannus
Justin Tan
Weon-Young Son
Michael-Haim Dahan
Publication date
01-04-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 4/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4642-z

Other articles of this Issue 4/2018

Archives of Gynecology and Obstetrics 4/2018 Go to the issue